Dreger, Peter
Heidelberg University
4 papers on CoChatORCID 0000-0002-7429-8570
Most cited papers
- Verified
A non-antibiotic-disrupted gut microbiome is associated with clinical responses to CD19-CAR-T cell cancer immunotherapy
Stein-Thoeringer, C. K., Saini, N. Y., Zamir, E., Blumenberg, V., Schubert, M.-L., Mor, U., Fante, M. A., Schmidt, S., Hayase, E., Hayase, T., et al. (2023) · Nature Medicine
CAR-T cell therapy researchGut microbiota and health
Cited by 255
- Verified
Effects of physical exercise on survival after allogeneic stem cell transplantation
Wiskemann, J., Kleindienst, N., Kuehl, R., Dreger, P., Schwerdtfeger, R., & Bohus, M. (2015) · International Journal of Cancer
Cancer survivorship and careHematopoietic Stem Cell Transplantation
Cited by 96
- Verified
Optimized Assessment of qPCR-Based Vector Copy Numbers as a Safety Parameter for GMP-Grade CAR T Cells and Monitoring of Frequency in Patients
Kunz, A., Gern, U., Schmitt, A., Neuber, B., Wang, L., Hückelhoven-Krauss, A., Michels, B., Hofmann, S., Müller-Tidow, C., Dreger, P., et al. (2020) · Molecular Therapy - Methods & Clinical Development
CAR-T cell therapy researchVirus-based gene therapy research
Cited by 54
- Verified
CD22 CAR T-cell therapy: new hope for patients with large B-cell lymphoma
Schubert, M.-L., & Dreger, P. (2024) · The Lancet
CAR-T cell therapy researchLymphoma Diagnosis and Treatment
Cited by 3
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free